Phio Appoints Dr. Todd Plott to Board of Directors
Phio Pharmaceuticals announced the appointment of dermatologist Todd Plott to its board. The addition is expected to support the development of the company's siRNA drug candidate PH-762 for treating squamous cell carcinoma.
View filing at SEC.gov →